{"id":249,"date":"2022-10-07T06:18:43","date_gmt":"2022-10-07T11:18:43","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=areas-de-trabajo&#038;p=249"},"modified":"2023-05-02T11:16:47","modified_gmt":"2023-05-02T16:16:47","slug":"access-to-innovative-medicines","status":"publish","type":"areas-de-trabajo","link":"https:\/\/fifarma.org\/en\/areas-de-trabajo\/acceso-a-medicamentos-innovadores\/","title":{"rendered":"Access to Innovative Medicines"},"content":{"rendered":"<h2 class=\"wp-block-heading\">Every day, hundreds of thousands of people in Latin America and the Caribbean wait for treatment to renew their hope of regaining their health.<\/h2>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>The value of health is of paramount importance when quality of life or life expectancy is at stake. It is at times when illnesses completely disrupt the well-being and peace of mind of patients and their families that we are reminded of the value of healthcare systems, innovative medicines and the industry that produces them.<\/p>\n\n\n\n<p>The problem is that the solution does not lie in the hands of a single sector, but in the articulation of many wills that must work as a team to achieve significant results.<\/p>\n\n\n\n<p>In addition to the treatment of diseases, FIFARMA recognizes the power of prevention in health. The relationship with patients must include this vital component, which benefits all people and lightens the burden of care in the region's healthcare systems.<\/p>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Patients at the core of the industry<\/h3>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Patients are at the heart of what the pharmaceutical industry does. Their hopes and those of their families motivate us to undertake, with passion and responsibility, new scientific research and to develop innovative products and therapies to mitigate the effects of disease.\u00a0<\/p>\n\n\n\n<p>However, in many regions, and particularly in Latin America and the Caribbean, the availability of and access to these advances in pharmaceutical innovation remains low and time-consuming, disproportionately affecting the most vulnerable patients.<\/p>\n\n\n\n<p>The FIFARMA W.A.I.T Indicator 2022 developed by IQVIA, which is the first study on availability and access to 185 innovative oncology and rare disease drugs and therapies in 8 Latin American countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, and Peru, shows that the average delay between marketing authorization and patient access varies from 1.5 years to more than 3.5 years, and the average rate of availability of these drugs is 13%.<\/p>\n\n\n\n<p>At FIFARMA we defend equity in health systems and the co-responsibility of all its actors, in order to achieve the greatest benefit for patients, regardless of their age or socioeconomic status. We understand that timely access to innovative drugs can in no way be a privilege or a luxury service, but a matter of social equity.\u00a0<\/p>\n\n\n\n<p>Este estudio representa una oportunidad para analizar detalladamente las barreras y los retrasos, y adquirir compromisos concretos entre todos los actores del sector salud para reducir tiempos de acceso y aumentar la disponibilidad de los medicamentos innovadores, teniendo en cuenta la sostenibilidad de los sistemas sanitarios. Esto nos demuestra que la soluci\u00f3n no est\u00e1 en manos de un solo sector, sino en la articulaci\u00f3n de muchas voluntades que deben trabajar en equipo para lograr resultados significativos.<\/p>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image size-large is-style-default\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/AdobeStock_263593710-1024x683.jpeg\" alt=\"\" class=\"wp-image-1708\" srcset=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/AdobeStock_263593710-1024x683.jpeg 1024w, https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/AdobeStock_263593710-300x200.jpeg 300w, https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/AdobeStock_263593710-768x512.jpeg 768w, https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/AdobeStock_263593710-1536x1024.jpeg 1536w, https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/AdobeStock_263593710-2048x1365.jpeg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" width=\"580\" height=\"400\" src=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/Mask-group.jpg\" alt=\"\" class=\"wp-image-10\" srcset=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/Mask-group.jpg 580w, https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/Mask-group-300x207.jpg 300w\" sizes=\"(max-width: 580px) 100vw, 580px\" \/><\/figure>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">A call for public-private collaboration<\/h3>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>If we can co-create solutions that make viable healthcare ecosystems more sustainable and with greater opportunity for early drug and treatment innovation, we can transform the lives of many patients who yearn for a better future.<\/p>\n\n\n\n<p>La soluci\u00f3n es entonces la articulaci\u00f3n de muchas voluntades que deben trabajar en equipo para lograr resultados sostenibles. Queremos consolidar a FIFARMA como esa fuerza colectiva que nutra y aporte en el debate p\u00fablico, y que pueda articular estas soluciones conjuntas con actores, p\u00fablicos y privados del sector salud para as\u00ed juntos encontrar una nueva forma de pensar la salud regional, desde la innovaci\u00f3n, con la participaci\u00f3n activa de los pacientes y cuidadores.\u00a0Nuestra lucha es por mejorar la calidad de vida de los pacientes de la regi\u00f3n. Y de esa manera, mejorar tambi\u00e9n la \u201c<strong>social and economic health<\/strong>\" of our countries. A nation with better health is more productive, competitive, and equitable.<\/p>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong>DOCUMENTS AND PUBLICATIONS\u00a0<\/strong><\/p>\n\n\n\n<p>Financial affordability interventions to leverage technological innovation in health in Latin America and the Caribbean<\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/fifarma_msh_informe_argentina_infografia.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Report on Argentina<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/fifarma_msh_informe_colombia_infografia.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Report on Colombia<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/07.-Fifarma-Informe_Costa_Rica.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Report on Costa Rica<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/fifarma_msh_informe_chile_infografia.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Report on Chile<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/fifarma_msh_informe_ecuador_infografia.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Report on Ecuador<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/fifarma_msh_informe_mexico_infografia.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Report on Mexico<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/05.-Fifarma-Informe_Panama.pdf\">Report on Panama<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/02.-Fifarma-Informe_Peru.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Report on Peru<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/fifarma_msh_informe_RD_infografia.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Report on The Dominican Republic<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/fifarma_msh_informe_uruguay.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Report on Uruguay<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/12\/FIFARMA-WAIT-Indicator-2022_Report_vFinal-30SEP2022-4.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">WAIT INDICATOR 2022\u00a0<\/a><\/p>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div>","protected":false},"featured_media":1744,"template":"","class_list":["post-249","areas-de-trabajo","type-areas-de-trabajo","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Acceso a Medicamentos Innovadores - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/en\/work-areas\/access-to-innovative-medicines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acceso a Medicamentos Innovadores\" \/>\n<meta property=\"og:description\" content=\"Cada d\u00eda, cientos de miles de personas en Latinoam\u00e9rica y el Caribe esperan un tratamiento que les renueve la esperanza de recuperar su salud. El valor de la salud cobra una importancia capital cuando est\u00e1n en juego la calidad o la expectativa de vida. Es en los momentos en que las enfermedades alteran por completo [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/en\/work-areas\/access-to-innovative-medicines\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T16:16:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/AdobeStock_314281433-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"819\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/areas-de-trabajo\\\/acceso-a-medicamentos-innovadores\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/areas-de-trabajo\\\/acceso-a-medicamentos-innovadores\\\/\",\"name\":\"Acceso a Medicamentos Innovadores - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/areas-de-trabajo\\\/acceso-a-medicamentos-innovadores\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/areas-de-trabajo\\\/acceso-a-medicamentos-innovadores\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_314281433-scaled.jpeg\",\"datePublished\":\"2022-10-07T11:18:43+00:00\",\"dateModified\":\"2023-05-02T16:16:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/areas-de-trabajo\\\/acceso-a-medicamentos-innovadores\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/areas-de-trabajo\\\/acceso-a-medicamentos-innovadores\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/areas-de-trabajo\\\/acceso-a-medicamentos-innovadores\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_314281433-scaled.jpeg\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AdobeStock_314281433-scaled.jpeg\",\"width\":2560,\"height\":819},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/areas-de-trabajo\\\/acceso-a-medicamentos-innovadores\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acceso a Medicamentos Innovadores\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Acceso a Medicamentos Innovadores - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/en\/work-areas\/access-to-innovative-medicines\/","og_locale":"en_US","og_type":"article","og_title":"Acceso a Medicamentos Innovadores","og_description":"Cada d\u00eda, cientos de miles de personas en Latinoam\u00e9rica y el Caribe esperan un tratamiento que les renueve la esperanza de recuperar su salud. El valor de la salud cobra una importancia capital cuando est\u00e1n en juego la calidad o la expectativa de vida. Es en los momentos en que las enfermedades alteran por completo [&hellip;]","og_url":"https:\/\/fifarma.org\/en\/work-areas\/access-to-innovative-medicines\/","og_site_name":"FIFARMA","article_modified_time":"2023-05-02T16:16:47+00:00","og_image":[{"width":2560,"height":819,"url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/AdobeStock_314281433-scaled.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/areas-de-trabajo\/acceso-a-medicamentos-innovadores\/","url":"https:\/\/fifarma.org\/areas-de-trabajo\/acceso-a-medicamentos-innovadores\/","name":"Acceso a Medicamentos Innovadores - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fifarma.org\/areas-de-trabajo\/acceso-a-medicamentos-innovadores\/#primaryimage"},"image":{"@id":"https:\/\/fifarma.org\/areas-de-trabajo\/acceso-a-medicamentos-innovadores\/#primaryimage"},"thumbnailUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/AdobeStock_314281433-scaled.jpeg","datePublished":"2022-10-07T11:18:43+00:00","dateModified":"2023-05-02T16:16:47+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/areas-de-trabajo\/acceso-a-medicamentos-innovadores\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/areas-de-trabajo\/acceso-a-medicamentos-innovadores\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fifarma.org\/areas-de-trabajo\/acceso-a-medicamentos-innovadores\/#primaryimage","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/AdobeStock_314281433-scaled.jpeg","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/AdobeStock_314281433-scaled.jpeg","width":2560,"height":819},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/areas-de-trabajo\/acceso-a-medicamentos-innovadores\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Acceso a Medicamentos Innovadores"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Latin American Federation of the Pharmaceutical Industry","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/areas-de-trabajo\/249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/areas-de-trabajo"}],"about":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/types\/areas-de-trabajo"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/media\/1744"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/media?parent=249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}